Next Article in Journal
Integrating Comorbidities and Phenotype-Based Medicine in Patient-Centered Medicine in COPD
Next Article in Special Issue
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study
Previous Article in Journal
Building a Parkinson-Network–Experiences from Germany
Previous Article in Special Issue
The Hypotension Period after Initiation of Appropriate Antimicrobial Administration Is Crucial for Survival of Bacteremia Patients Initially Experiencing Severe Sepsis and Septic Shock
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?

1
Antimicrobial Stewardship Unit, Department of medicine, St. Maria Hospital, 05100 Terni, Italy
2
Department of Critical Care Medicine and Anesthesiology, St. Maria Hospital, 05100 Terni, Italy
3
Infectious Diseases Clinic, Department of medicine, St. Maria Hospital, 05100 Terni, Italy
4
Pharmacy Unit, St. Maria Hospital, 05100 Terni, Italy
5
Hematology and Microbiology Laboratory, St. Maria Hospital, 05100 Terni, Italy
6
Department of General and Specialist Surgery “Paride Stefanini”, 00185 Rome, Italy
7
Section of Legal Medicine, St. Maria Hospital, 05100 Terni, Italy
8
Department of General and Oncologic Surgery, St. Maria Hospital, 05100 Terni, Italy
9
Department of General and Oncologic Surgery, University of Perugia, St. Maria Hospital, 05100 Terni, Italy
*
Author to whom correspondence should be addressed.
Submission received: 15 July 2020 / Revised: 16 August 2020 / Accepted: 24 August 2020 / Published: 25 August 2020

Abstract

:
The Italian burden of disease associated with infections due to antibiotic-resistant bacteria has been very high, largely attributed to Carbapenem-Resistant Klebsiella pneumoniae (CR-Kp). The implementation of infection control measures and antimicrobial stewardship programs (ASP) has been shown to reduce healthcare-related infections caused by multidrug resistance (MDR) germs. Since 2016, in our teaching hospital of Terni, an ASP has been implemented in an intensive care unit (ICU) setting, with the “daily-ICU round strategy” and particular attention to infection control measures. We performed active surveillance for search patients colonized by Carbapenem-Resistant Enterobacteriaceae (CRE). In March 2020, coronavirus disease 2019 (COVID-19) arrived and the same ICU was reserved only for COVID-19 patients. In our retrospective observational study, we analyzed the bimonthly incidence of CRE colonization patients and the incidence of CRE acquisition in our ICU during the period of January 2019 to June 2020. In consideration of the great attention and training of all staff on infection control measures in the COVID-19 era, we would have expected a clear reduction in CRE acquisition, but this did not happen. In fact, the incidence of CRE acquisition went from 6.7% in 2019 to 50% in March–April 2020. We noted that 67% of patients that had been changed in posture with prone position were colonized by CRE, while only 37% of patients that had not been changed in posture were colonized by CRE. In our opinion, the high intensity of care, the prone position requiring 4–5 healthcare workers (HCWs), equipped with personal protective equipment (PPE) in a high risk area, with extended and prolonged contact with the patient, and the presence of 32 new HCWs from other departments and without work experience in the ICU setting, contributed to the spread of CR-Kp in our ICU, determining an increase in CRE acquisition colonization.

1. Introduction

The European burden of disease associated with infections owing to antibiotic-resistant bacteria was very high as far as Italy was concerned, with 10,762 deaths in 2015 [1]. A large contribution was owing to carbapenem-resistant Klebsiella pneumoniae (CR-Kp), with a high mortality (30–70%) [2]. The implementation of infection control measures for reducing in-hospital transmission of CR-Kp and of antimicrobial stewardship programs have been shown to reduce healthcare-related infections caused by multidrug resistance (MDR) germs [3]. The European Centre for Disease Control (ECDC) reported that, in Europe, 7.5% of Klebsiella pneumoniae isolated from blood cultures and cerebral spinal fluid were resistant to carbapenems, while in Italy, it was 26.8% [4]. During the ECDC visit to Italy in order to discuss antimicrobial resistance (AMR) issues, it was reported that the AMR situation is one of the major Italian health problems, hence warning to urgently introduce measures for the appropriate use of the antibiotics and to improve infection control [5]. Organization for Economic Co-operation and Development (OECD) declared that, in Italy, there are higher than average rates of healthcare associated infections and the total volume of antibiotics prescribed is the second highest in the OECD. In our 554-bed teaching hospital, an antimicrobial stewardship program (ASP) has been active since 2016, with particular attention to the intensive care unit (ICU) setting and infection control measures. In March 2020, COVID-19 arrived and the infection control became essential to prevent the spread of Sars-CoV-2. In this article, we report an observational retrospective analysis to evaluate the incidence of Carbapenem-Resistant Enterobacteriaceae (CRE) colonization and CRE acquisition in the ICU in pre-COVID-19 era, during the COVID-19 pandemic, and in post-COVID-19 era.

2. Materials and Methods

2.1. Setting

Since 2016, in our teaching hospital of Terni (Umbria, Italy), with 554 hospital beds, an ASP has been implemented in our ICU setting with 14 beds. The ICU cares for a mixed population of post-surgical patients and patients suffering from life-threatening respiratory and cardiovascular conditions as well as trauma, sepsis shock, and so on. The core strategy of our ASP was a “daily-ICU round strategy”, in which the infectious disease expert in antimicrobial stewardship takes review of antibiotics daily, discussing them with the intensivist about de-escalation, withdraw when infection was not confirmed, stopping antibiotic therapy for the end of treatment, using a nudge approach.

2.2. Infection Control Policy

Particular attention was given to infection control practices with hand hygiene intervention, definition by checklist and continuous training on contact precautions for CRE carriers. We also performed active surveillance through systematic screening with rectal swab and clinical culture to search patients colonized by CRE, performed on all new ICU admissions and tested again on the seventh day of hospitalization. Bimonthly data were shared with ICU staff in regular meetings [3].
The surveillance test to detect CRE on rectal swab was a culture-based method with a direct inoculation into specific selective chromogenic media. Growing colonies were identified by Vitek-MS, matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF, bioMeriéux), and tested for carbapenems resistance and antibiotic susceptibility using the Vitek 2 system (bioMerieux, Marcy-L’Étoile, France). Enterobacteriaceae colonies were also analyzed by immunochromatography test, for the identification of OXA-48-like, OXA carbapenemase (OXA-163), Klebsiella Pneumoniae Carbapenemase (KPC), New Delhi Metallo-beta-lactamase (NDM), and Verona Imipenemase (VIM) carbapenemases (RESIST-5 O.O.K.N.V. CORIS BioConcept, Allschwil, The Switzerlands).

2.3. COVID-19 Situation in Italy

In March 2020, Sars-CoV-2 arrived in our hospital. The same ICU became an ICU only for COVID-19 patients. All the healthcare workers (HCWs) in COVID-19 ICU wore personal protective equipment (PPE) in accordance with the World Health Organization (WHO) and Italian guidelines [6,7].
During the pandemic period, the number of HCWs in the ICU increased, in 24 h of work, 33 HCWs changed shifts. Therefore, 32 new members, from other departments and without work experience in the ICU setting, started working in the ICU.
All the patients admitted to the ICU received systematic screening for colonization of CRE through rectal swabbing or clinical culture (bronchoalveolar lavage or urine colture). During the ICU stay, the patients continued to be systematically screened through rectal swab for CRE colonization every 7 days and routine microbiological culture of bronchoalveolar lavage and urine culture. The patients with a site of colonization at the admission in the ICU were defined as primary colonization cases. The patients with “CRE acquisition” were considered the patients with a site of colonization obtained after a negative swab or clinical culture at ICU admission [8].
We analyzed the bimonthly incidence of CRE colonization patient and the incidence of CRE acquisition in our ICU from 1 January 2019 to June 2020. We analyzed the trend of the phenomenon before COVID-19 era, during the pandemic (March–April 2020) when the same ICU was reserved only for COVID-19 patients, and after COVID-19 era (May–June 2020) when the ICU was COVID-19 free.

3. Results

We analyzed bimonthly data from January–February 2019 to May–June 2020 concerning the number of patients admitted to the ICU and number of rectal carriers of CRE (Table 1). We analyzed the trend of incidence of primary and CRE acquisition cases (Figure 1).
In the first two months (January and February) of 2019, 3.1% of cases were primary colonization cases and 4.6% CRE acquisition. Successively, in March–April 2019, the overall incidence was higher (15%), but the incidence rate of CRE acquisition cases was lower (3.3%). In May–June 2019, 5.3% of cases were CRE acquisition cases. In July–August 2019, CRE acquisition shown a slight increase in the incidence rate compared with the previous two months (8.2%). In September–October 2019, there was the highest incidence rate of CRE colonized patients, 21%, but the CRE acquisition was only 1, with the lowest incidence rate of 2.3%. In November–December 2019, 31 patients were admitted with 4 colonized CRE patients, of which 2 CRE were acquisition cases.
In January–February 2020, 25 patients were admitted with only 1 primary colonization case.
From January 2019 to February 2020, the patients admitted to the ICU were a mixed population of post-surgical patients (neurosurgery, abdominal surgery, urological surgery, thoracic surgery, and so on) or patients suffering from life-threatening conditions such as septic shock, acute respiratory failure, trauma, and so on. Patients may be admitted from surgical wards or the emergency department or from any ward if they had conditions that warranted intensive care. The ASP did “daily-ICU round strategy”, with the daily discussion about antibiotic therapy microbiological samples, and diagnosis of healthcare associated infections (HAIs) and infection control measures application.
On 20 February 2020 Sars-CoV-2 arrived in Italy and, on 4 March 2020, the first COVID-19 case arrived in our hospital.
In March 2020, the same ICU with 14 beds become an ICU only for COVID-19 patients. All the patients admitted had a Sars-CoV-2 isolation from a nasopharyngeal or oropharyngeal or bronchoalveolar sample and all patients needed ventilator support by oro-tracheal intubation. The HCWs in the COVID-19 ICU were trained on donning and doffing PPE. In accordance with the indications of the Ministry of Health, all staff were wearing gloves, eye protection, full coveralls, N95 respirators, or respirators that offer a higher level of protection and are worn for a session of work in a high risk area such as a COVID-19 ICU. The COVID-19 patients in ICU needed a high intensity of care, such as being changed in posture with the prone position for 12 to 16 h per day. About 4–5 HCWs were needed for posture changes of a patient. In 24 h of work in the COVID-19 ICU, 33 HCWs changed shifts, of which 32 were from other departments and without work experience in the ICU setting.
In March–April 2020, 32 patients were admitted to COVID-19 ICU for Sars-CoV-2-related acute respiratory distress syndrome (ARDS). Of these, 17 patients were CRE colonization: 1 was defined as a primary colonization case and 16 were defined as CRE acquisition with an incidence of 50%. Analyzing the trend of incidence of primary and CRE acquisition, we can say that, before the COVID-19 era, the average of incidence of primary cases was 12.3% (range 4–14.3%) and the average CRE acquisition was 4.3% (range 0–8.2%) with a constant trend. In the COVID-19 ICU (March–April 2020), the incidence of CRE acquisition increased significantly, as shown in Figure 1.
In May–June 2020, the ICU was COVID-19 free. During this period, 30 patients were admitted, of which 4 were colonized patients, all defined as primary cases. The analysis of the incidence of the acquired cases showed a decreasing trend from 50% to 0%.
The trend of incidence of CRE acquisition colonization is shown in Figure 2.
All the CRE isolated were Klebsiella pneumoniae KPC (Klebsiella Pneumoniae Carbapenemase). Out of the 32 ARDS COVID-19 patients, 18 were pronate and 14 were not. Of the 18 pronate patients, about 12 were colonized by CRE (1 primary colonization cases and 11 CRE acquisition cases). Out of the 14 not pronate patients, 5 were colonized by CRE and all cases were CRE acquisition cases. The data are reported in Figure 3.

4. Discussion

Curbing the spread of CRE into healthcare facilities is important as is controlling transmission in areas where they have become endemic, such as Italy, because they are associated with poor patient outcomes. Implementing infection control measures is an important step in order to prevent patients from becoming colonized or infected by CRE.
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the management of infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospital patients define the implementation of hand hygiene education programmes, contact precautions, use of alert code to identify promptly patients colonized by CRE, isolate colonized and infected patients, implementation of a programme of active screening culture, and implementation of an antimicrobial stewardship program as a strong recommendation [3]. All these recommendations have been implemented in our ASP active in the ICU since 2016. In 2019, the average incidence rate of CRE acquisition cases in our ICU was 5%.
In a few months, COVID-19 has transformed the world. The situation in Italy has been made dramatic in all social contexts [9]. Infection control becomes essential to contain and mitigate the risk of nosocomial transmission and outbreak; therefore, all suspected cases in our hospital were isolated for contact, droplet, and airborne precautions.
In March 2020, the intensive care unit became a department dedicated exclusively to COVID-19 intubated patients, defined as a high risk setting for the risk of transmission to healthcare workers. All the HCWs were trained on donning and doffing PPE, all staff had access to the PPE to protect themselves, gloves and aprons were subject to single use as with disposal after each patient or resident contact, fluid repellent surgical mask and eye protection were used for a session of work, gowns or coveralls were worn for a session of work in higher risk areas, and hand hygiene was practiced and extended to exposed forearms after removing any element of PPE [10]. Considering the high number of HCWs employed (in 24 h of work in the COVID-19 ICU, 33 HCWs worked in shifts), we can affirm that the use of PPE was effective in order to protect them because no healthcare professionals tested were positive for Sars-CoV-2.
In consideration of the great attention and training of all staff on infection control measures, we would have expected a clear reduction in CRE acquisition, but this did not happen; in fact, the incidence of CRE acquisition went from 5% on average in 2019 to 50% during the pandemic (March–April 2020). Therefore, the use of PPE was correct and protected the HCWs, but this did not protect patients from CRE acquisition colonization. During the pandemic period, HCWs from other departments without work experience in the ICU setting started working in ICU.
In addition, we noted that the 67% of patients that were changed in posture with prone position were colonized by CRE, while the 37% of patients that were not changed in posture were colonized by CRE. The mechanism of CRE acquisition is the microbe cross-transmission, which is summarized by the World Health Organization (WHO) with the presence of microbes in patient, transfer of this organism to HCWs, and cross-transmission to other patients [11].
Incorrect hand cleaning during patient care has been demonstrated to facilitate the cross-transmission of Gram negative bacteria (GNB) [12]. GNB survive on hands for periods lasting from a few minutes to several hours [13]. Hand contamination despite wearing gloves has been reported in 4.5% and 1% of HCWs [14]. It has also been demonstrated that the Klebsiella spp. contamination of staff took place after simple procedures and the GNB counts on HCWs are related to the type of contact [15,16].
The clothing of healthcare staff can be a source for cross-transmission of healthcare-associated pathogens [17,18,19,20,21,22]. The contamination of gowns and gloves has been shown to be a frequent event during patient care; transfer of Klebsiella spp. to staffs’ hands took place after simple “clean” procedures such as washing the patients and touching several parts of the body during daily activities [14,23,24].
The COVID-19 patients recovering in the ICU are patients with a high intensity of care, with a continuous need for assistance, and thus a continuous need to be touched by the HCWs, such as the need to be pronated. To change a patient in prone position required the employment of 4–5 HCWs equipped with all the necessary PPE. The incidence rate of colonized CRE patients was higher in patients pronated (67%) rather than in not pronated. The HCWs, in accordance with the indication of the Ministry of Health, must wear gowns or coveralls for a session of work because they are in higher risk areas.
Therefore, in our opinion, the high intensity of care, the need to be changed in prone position with the employment of 4–5 HCWs equipped with PPE in a high risk area with extended and prolonged contact with the patient, and the presence of health personnel without work experience in ICU setting regarding contact precautions contributed to the spread of Klebsiella pneumoniae KPC in our ICU, determining an increased in CRE acquisition colonization.
After the pandemic, the type of patients and ICU staff members returned to that of the pre COVID-19 era. The result was that the incidence of CRE acquisition went from 50% to 0%.

5. Conclusions

Working during a pandemic event in a high risk setting like the COVID-19 ICU is more difficult because of the use of PPE. The ARDS Sars-CoV-2 patients are patients requiring high intensity of care with the employment of many HCWs. Many COVID-19 patients needed to be changed to prone position for 12 to 16 h per day, and this maneuver creates prolonged and extended contact between the patient and the operator. Our study highlighted how this is probably the root cause of the Klebsiella pneumoniae KPC spread in the COVID-19 ICU.

Author Contributions

Conceptualization: B.T. and S.C.; Data curation: B.T., G.P., and P.A.; Investigation: B.T., E.S., V.M., and M.C. (Mizar Cantarini); Methodology: B.T., R.C., and S.C.; Project administration: S.C.; Supervision: S.C.; Visualization: M.C. (Monya Costantini), F.S., and M.F.; Writing-original draft: B.T., A.M., and R.C.; Writing-review & editing: G.P., C.V., L.A.M., and P.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cassini, A.; Högberg, L.D.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Simonsen, G.S.; Colomb-Cotinat, M.; Kretzschmar, M.E.; Devleesschauwer, B.; Burden of AMR Collaborative Group; et al. Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis. Lancet Infect. Dis. 2019, 1, 56–66. [Google Scholar] [CrossRef] [Green Version]
  2. Tumbarello, M.; Viale, P.; Viscoli, C.; Trecarichi, E.M.; Tumietto, F.; Marchese, A.; Spanu, T.; Ambretti, S.; Ginocchio, F.; Cristini, F.; et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: Importance of combination therapy. Clin. Infect. Dis. 2012, 55, 943–950. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Tacconelli, E.; Cataldo, M.A.; Dancer, S.J.; De Angelis, G.; Falcone, M.; Frank, U.; Kahlmeter, G.; Pan, A.; Petrosillo, N.; Rodríguez-Baño, J.; et al. European Society of Clinical Microbiology. ESCMID Guidelines for the Management of the Infection Control Measures to Reduce Transmission of Multidrug-Resistant Gram-negative Bacteria in Hospitalized Patients. Clin. Microbiol. Infect. 2014, 20 (Suppl. 1), 1–55. [Google Scholar] [CrossRef] [Green Version]
  4. European Centre for Disease Prevention and Control. Surveillance of Antimicrobial Resistance in Europe 2018; ECDC: Stockholm, Sweden, 2019. [Google Scholar]
  5. European Centre for Disease Prevention and Control. ECDC Country Visit to Italy to Discuss Antimicrobial Resistance Issues; ECDC: Stockholm, Sweden, 2017. [Google Scholar]
  6. World Health Organization. Rational Use of Personal Protective Equipment for Coronavirus Disease (COVID-19): Interim Guidance; License: CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, Switzerland, 2020. Available online: https://apps.who.int/iris/handle/10665/331215 (accessed on 27 February 2020).
  7. Interim Guidance for Rational Use of SARS-COV-2 Infection Protections in Health and Socio-Health Activities in the Current SARSCOV-2 Emerging Scenario; Version of May 10, 2020; ISS Working Group COVID-19 Infections Prevention and Control: Rome, Italy, 2020; p. Rapporto ISS COVID-19 n. 2/2020Rev. 2. (In Italian)
  8. Horan, T.C.; Andrus, M.; Dudeck, M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 2008, 36, 309–332. [Google Scholar] [CrossRef] [PubMed]
  9. Cingolani, M.; Caraceni, L.; Cannovo, N.; Fedeli, P. The COVID-19 Epidemic and the Prison System in Italy. J. Correct. Health Care 2020. [Google Scholar] [CrossRef] [PubMed]
  10. Public Health England. Guidance COVID-19 Personal Protective Equipment (PPE). Available online: https://www.gov.uk/government/collections/coronavirus-covid-19-personal-protective-equipment-ppe (accessed on 12 June 2020).
  11. World Health Organization. Implementation Manual to Prevent and Control the Spread of Carbapenem-Resistant Organisms at the National and Health Care Facility Level; (WHO/UHC/SDS/2019.6); Licence: CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
  12. Pittet, D.; Dharan, S.; Touveneau, S.; Sauvan, V.; Perneger, T.V. Bacterial Contamination of the Hands of Hospital Staff during Routine Patient Care. Arch. Intern. Med. 1999, 159, 821–826. [Google Scholar] [CrossRef] [PubMed]
  13. Adams, B.G.; Marrie, T.G. Hand Carriage of Aerobic Gram-negative Rods by Health Care Personnel. J. Hyg. (Lond.) 1982, 89, 23–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Morgan, D.J.; Liang, S.Y.; Smith, C.L.; Johnson, J.K.; Harris, A.D.; Furuno, J.P.; Thom, K.A.; Snyder, G.M.; Day, H.R.; Perencevich, E.N. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect. Control Hosp. Epidemiol. 2010, 31, 716–721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Grice, E.A.; Segre, J.A. The Skin Microbiome. Rev. Nat. Rev. Microbiol. 2011, 9, 244–253. [Google Scholar] [CrossRef] [PubMed]
  16. Davis, C.P. Normal Flora. In Medical Microbiology, 4th ed.; Baron, S., Ed.; University of Texas Medical Branch at Galveston: Galveston, TX, USA, 1996; Chapter 6. [Google Scholar]
  17. Wiener-Well, Y.; Galuty, M.; Rudensky, B.; Schlesinger, Y.; Attias, D.; Yinnon, A.M. Nursing and physician attire as possible source of nosocomial infections. Am. J. Infect. Control 2011, 39, 555–559. [Google Scholar] [CrossRef]
  18. Perry, C.; Marshall, R.; Jones, E. Bacterial contamination of uniforms. J. Hosp. Infect. 2001, 48, 238–241. [Google Scholar] [CrossRef]
  19. Wilson, J.A.; Loveday, H.P.; Hoffman, P.N.; Pratt, R.J. Uniform: An evidence review of the microbiological significance of uniforms and uniform policy in the prevention and control of healthcare-associated infections. Report to the Department of Health (England). J. Hosp. Infect. 2007, 66, 301–307. [Google Scholar] [CrossRef] [PubMed]
  20. Babb, J.R.; Davies, J.G.; Ayliffe, G.A. Contamination of protective clothing and nurses’ uniforms in an isolation ward. J. Hosp. Infect. 1983, 4, 149–157. [Google Scholar] [CrossRef]
  21. Wong, D.; Nye, K.; Hollis, P. Microbial flora on doctors’ white coats. Br. Med. J. 1991, 303, 1602–1604. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Speers, R., Jr.; Shooter, R.A.; Gaya, H.; Patel, N. Contamination of nurses’ uniforms with Staphylococcus aureus. Lancet 1969, 2, 233–235. [Google Scholar] [CrossRef]
  23. Morgan, D.J.; Rogawski, E.; Thom, K.A.; Johnson, J.K.; Perencevich, E.N.; Shardell, M.; Leekha, S.; Harris, A.D. Transfer of multidrug-resistant bacteria to healthcare workers’ gloves and gowns after patient contact increases with environmental contamination. Crit. Care Med. 2012, 40, 1045–1051. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Casewell, M.; Phillips, I. Hands as route of transmission for Klebsiella species. Br. Med. J. 1977, 2, 1315–1317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. The trend of incidence of primary Carbapenem-Resistant Enterobacteriaceae (CRE) and acquisition CRE in intensive care unit (ICU).
Figure 1. The trend of incidence of primary Carbapenem-Resistant Enterobacteriaceae (CRE) and acquisition CRE in intensive care unit (ICU).
Jcm 09 02744 g001
Figure 2. The trend of incidence of CRE acquisition colonization.
Figure 2. The trend of incidence of CRE acquisition colonization.
Jcm 09 02744 g002
Figure 3. Data about the acute respiratory distress syndrome (ARDS) coronavirus disease 2019 (COVID-19) patients pronate and not pronate and CRE colonization.
Figure 3. Data about the acute respiratory distress syndrome (ARDS) coronavirus disease 2019 (COVID-19) patients pronate and not pronate and CRE colonization.
Jcm 09 02744 g003
Table 1. Bimonthly data from January 2019 to June 2020 about number of patients admitted to intensive care unit (ICU) and number of Carbapenem-Resistant Enterobacteriaceae (CRE) colonization.
Table 1. Bimonthly data from January 2019 to June 2020 about number of patients admitted to intensive care unit (ICU) and number of Carbapenem-Resistant Enterobacteriaceae (CRE) colonization.
Patients (Total)CRE Colonized Patients (N)CRE Colonized Patients (%)Primary Cases (Patients)Acquisition Cases (Patients)% Acquisition Cases (Patients)
Jan—Feb 20196557.7%234.6%
Mar—Apr 201960915.0%723.3%
May—Jun 2019561018.0%735.3%
Jul—Aug 201949714.3%348.2%
Sep—Oct 201943921.0%812.3%
Nov—Dec 20193126.4%226.4%
Jan—Feb 20202514.0%100.0%
Mar—Apr 2020321753.0%11650.0%
May—Jun 202030413.3%400.0%

Share and Cite

MDPI and ACS Style

Tiri, B.; Sensi, E.; Marsiliani, V.; Cantarini, M.; Priante, G.; Vernelli, C.; Martella, L.A.; Costantini, M.; Mariottini, A.; Andreani, P.; et al. Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work? J. Clin. Med. 2020, 9, 2744. https://doi.org/10.3390/jcm9092744

AMA Style

Tiri B, Sensi E, Marsiliani V, Cantarini M, Priante G, Vernelli C, Martella LA, Costantini M, Mariottini A, Andreani P, et al. Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work? Journal of Clinical Medicine. 2020; 9(9):2744. https://doi.org/10.3390/jcm9092744

Chicago/Turabian Style

Tiri, Beatrice, Emanuela Sensi, Viola Marsiliani, Mizar Cantarini, Giulia Priante, Carlo Vernelli, Lucia Assunta Martella, Monya Costantini, Alessandro Mariottini, Paolo Andreani, and et al. 2020. "Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?" Journal of Clinical Medicine 9, no. 9: 2744. https://doi.org/10.3390/jcm9092744

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop